Methods and compositions for detecting and modulating O-glycosylation
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-038/00
C12Q-001/37
C07K-007/06
C12Q-001/34
C12N-009/12
출원번호
US-0013860
(2013-08-29)
등록번호
US-8993718
(2015-03-31)
발명자
/ 주소
Gross, Benjamin J.
Kahne, Suzanne Walker
Swoboda, Jonathan G.
출원인 / 주소
President and Fellows of Harvard College
대리인 / 주소
Wolf, Greenfield & Sacks, P.C.
인용정보
피인용 횟수 :
1인용 특허 :
42
초록▼
The invention relates to methods and products for modulating glycosylation of proteins. The invention is useful for identifying therapeutic compounds to treat glycosylation-associated disorders such as neurodegeneration, diabetes, including complications of diabetes such as insulin resistance, nephr
The invention relates to methods and products for modulating glycosylation of proteins. The invention is useful for identifying therapeutic compounds to treat glycosylation-associated disorders such as neurodegeneration, diabetes, including complications of diabetes such as insulin resistance, nephropathy, microvascular damage, and endothelial dysfunction. The invention is also useful for identifying therapeutic compounds to treat de-glycosylation-associated disorders such as ischemic damage and traumatic injury. The invention also relates in part to assays that are useful for identifying and testing candidate compounds for modulating glycosylation of proteins and also relates in part to compounds to treat glycosylation-associated diseases and disorders.
대표청구항▼
1. An isolated molecule comprising a cleavable detectably labeled polypeptide substrate having a) an O-glycosylation site andb) a specific protease cleavage site positioned in the polypeptide such that the rate of cleavage by a specific protease at the specific protease cleavage site is different wh
1. An isolated molecule comprising a cleavable detectably labeled polypeptide substrate having a) an O-glycosylation site andb) a specific protease cleavage site positioned in the polypeptide such that the rate of cleavage by a specific protease at the specific protease cleavage site is different when the polypeptide is glycosylated at the O-glycosylation site than when the polypeptide is not glycosylated at the O-glycosylation site, wherein the detectable label is positioned in the polypeptide such that a change in the detectable label identifies cleavage of the polypeptide by the specific protease at the specific protease cleavage site. 2. The isolated molecule of claim 1, wherein the polypeptide O-glycosylation site is a serine or a threonine residue. 3. The isolated molecule of claim 2, wherein the serine or threonine is positioned within 1, 2, 3, or 4 amino acids of the specific protease cleavage site. 4. The isolated molecule of claim 1, wherein the specific protease cleavage site is a single site and there is only one specific protease cleavage site. 5. The isolated molecule of claim 1, wherein the specific protease cleavage site is positioned on the N-terminal side of the O-glycosylation site. 6. The isolated molecule of claim 1, wherein the specific protease cleavage site is positioned on the C-terminal side of the O-glycosylation site. 7. The isolated molecule of claim 1, wherein the detectable label comprises a fluorescent, enzyme, radioactive, metallic, biotin, chemiluminescent, or bioluminescent molecule. 8. The isolated molecule of claim 1, wherein the detectable label is a fluorescent moiety. 9. The isolated molecule of claim 8, wherein the change in the detectable label comprises a change in fluorescence of the fluorescent moiety. 10. The isolated molecule of claim 1, wherein the detectable label is a FRET donor and a FRET acceptor pair. 11. The isolated molecule of claim 10, wherein the FRET donor and acceptor pair is 7-diethylaminocoumarin-3-carboxylic acid (DEAC) and fluorescein isothiocyanate; [2-(1-sulfonyl-5-naphthyl)-aminoethylamide] EDANS and 4,4-dimethylazobenzene-4′carbonyl (DABCYL); fluorescein isothiocyanate and tetramethylrhodamine (TMR); or Tryptophan or tyrosine and dinitrophenyl moieties. 12. The isolated molecule of claim 8, wherein the fluorescent moiety is a Cy5.5 emitter or FITC, Texas red, tetramethylrhodamine (TMR), AlexaFluor dyes, HiLyte Fluorophores, or [2-(1-sulfonyl-5-naphthyl)-aminoethylamide] EDANS. 13. The isolated molecule of claim 1, wherein the polypeptide further comprises a quenching moiety. 14. The isolated molecule of claim 13, wherein the quenching moiety is QXL-520, BHQ3, Iowa black, 4,4-dimethylazobenzene-4′carbonyl (DABCYL), BHQ1, BHQ10, QXL-570, QXL-620, dinitrophenyl (DNP) containing groups, or QSY-7,9-21, or 35. 15. The isolated molecule of claim 1, wherein the polypeptide comprises an amino acid sequence selected from the group consisting of: STPVSSANMK (SEQ ID NO:1), STPVSFANMK (SEQ ID NO:2), STPVSRANMK (SEQ ID NO:3), EYIPTVFDNK (SEQ ID NO:4), EYRPTVFDNK (SEQ ID NO:5), EYIPTVDDNK (SEQ ID NO:6), EPGPTEAPK (SEQ ID NO:25), and EDAVTPGPK (SEQ ID NO:26). 16. The isolated molecule of claim 1, wherein the specific protease cleavage site is a proteinase K cleavage site, a trypsin cleavage site, a chymotrypsin cleavage site, a thermolysin cleavage site, Staphylococcal peptidase I cleavage site, Proline-endopeptidase cleavage site, Pepsin cleavage site, Glutamyl endopeptidase cleavage site, Factor Xa cleavage site, Granzyme B Lysyl endopeptidase cleavage site, Asp-N Endopeptidase cleavage site, or enterokinase cleavage site. 17. A kit for identifying an agent that modulates O-glycosylation, the kit comprising a package housing a first container containing a polypeptide of claim 1, and instructions for using the polypeptide to identify modulators of O-glycosylation. 18. The kit of claim 17, further comprising a second container containing the specific protease that cleaves at the specific protease site of the polypeptide. 19. The kit of claim 17, wherein the polypeptide comprises the amino acid sequence set forth as one of SEQ ID NOs:1-6, 25, or 26.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (42)
Peterson Steven F. (West Linn OR), Ampule filling device.
Hubbard Vance M. (Bedford) Brunson Welton K. (Bedford) Saied V. C. (Wichita Falls TX), Apparatus and method for raising a skin wheal and anesthetizing skin.
Lilley Stephen J. (Sawston GBX) Taylor Hugh F. (Sawston GBX) Theobald David R. (Huntingdon GBX) Carlson Craig J. (Andover MA) Rosen David I. (Arlington MA) Johnson Thomas R. (Milford NH), Medical injection system and method, gas spring thereof and launching device using gas spring.
Roger D. Cone ; Wei Fan ; Bruce A. Boston ; Robert A. Kesterton ; Dongsi Lu ; Wenbiao Chen, Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals.
Kent John S. (Cupertino CA) Lewis Danny H. (Birmingham AL) Sanders Lynda M. (Palo Alto CA) Tice Thomas R. (Birmingham AL), Microencapsulation of water soluble active polypeptides.
McKinnon ; Jr. Charles N. (Laguna Niguel CA) Peterson Steven F. (West Linn OR) Smith Paul E. (Tualatin OR) Nakagawa Takaaki (Tigard OR) Bartholomew Victor L. (Tigard OR), Needleless hypodermic injection device.
Peterson Steven F. (West Linn OR) McKinnon ; Jr. Charles N. (Laguna Niguel CA) Smith Paul E. (Tualatin OR) Nakagawa Takaaki (Tigard OR) Bartholomew Victor L. (Tigard OR), Needleless hypodermic injection methods and device.
Ferrara, Napoleone; Gao, Wei-Qiang; Goddard, Audrey; Gurney, Austin L.; Watanabe, Colin K.; Wood, William I., Secreted and transmembrane polypeptides and nucleic acids encoding the same.
Patel Satischandra P. (Livingston NJ) Bhalani Vinayak T. (Morris Plains NJ), Sustained release composition for oral administration of active ingredient.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.